483 Document: Joel Vandersluis, M.D., Aug 12, 2022

FDANews 483 Joel Vandersluis, M.D. Aug 12 2022 top
Yvette M. Lacour-Davis FDA Investigator

On Aug 12, 2022, the FDA inspected Joel Vandersluis, M.D.'s Dayton site. Explore the inspectional observations.